212 related articles for article (PubMed ID: 21900376)
1. Amelioration of experimental autoimmune uveoretinitis by aldose reductase inhibition in Lewis rats.
Yadav UC; Shoeb M; Srivastava SK; Ramana KV
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8033-41. PubMed ID: 21900376
[TBL] [Abstract][Full Text] [Related]
2. Aldose reductase deficiency protects from autoimmune- and endotoxin-induced uveitis in mice.
Yadav UC; Shoeb M; Srivastava SK; Ramana KV
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8076-85. PubMed ID: 21911582
[TBL] [Abstract][Full Text] [Related]
3. Aldose reductase inhibition prevents endotoxin-induced uveitis in rats.
Yadav UC; Srivastava SK; Ramana KV
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4634-42. PubMed ID: 17898287
[TBL] [Abstract][Full Text] [Related]
4. Exogenous nitric oxide inhibits experimental autoimmune uveoretinitis development in Lewis rats by modulation of the Th1-dependent immune response.
Kwak HJ; Yang YS; Pae HO; Kim YM; Chung HT
Mol Cells; 2001 Oct; 12(2):178-84. PubMed ID: 11710518
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells ameliorate experimental autoimmune uveoretinitis by comprehensive modulation of systemic autoimmunity.
Zhang X; Ren X; Li G; Jiao C; Zhang L; Zhao S; Wang J; Han ZC; Li X
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3143-52. PubMed ID: 21296818
[TBL] [Abstract][Full Text] [Related]
6. Effects of experimental ocular inflammation on ocular immune privilege.
Ohta K; Wiggert B; Taylor AW; Streilein JW
Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2010-8. PubMed ID: 10440255
[TBL] [Abstract][Full Text] [Related]
7. Prevention of experimental autoimmune uveoretinitis by vasoactive intestinal peptide.
Keino H; Kezuka T; Takeuchi M; Yamakawa N; Hattori T; Usui M
Arch Ophthalmol; 2004 Aug; 122(8):1179-84. PubMed ID: 15302659
[TBL] [Abstract][Full Text] [Related]
8. [Effects of leflunomide on experimental autoimmune uveitis in Lewis rats].
Fang C; Zhou D; Zhan S; He Y; Lin Z; Huang C; Li J
Zhonghua Yan Ke Za Zhi; 2015 Oct; 51(10):754-61. PubMed ID: 26693771
[TBL] [Abstract][Full Text] [Related]
9. Oral administration of interferon-beta suppresses experimental autoimmune uveoretinitis.
Suzuki J; Sakai J; Okada AA; Takada E; Usui M; Mizuguchi J
Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):314-21. PubMed ID: 11981647
[TBL] [Abstract][Full Text] [Related]
10. LX211 (voclosporin) suppresses experimental uveitis and inhibits human T cells.
Cunningham MA; Austin BA; Li Z; Liu B; Yeh S; Chan CC; Anglade E; Velagaleti P; Nussenblatt RB
Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):249-55. PubMed ID: 18708627
[TBL] [Abstract][Full Text] [Related]
11. S-nitrosoglutathione prevents interphotoreceptor retinoid-binding protein (IRBP(161-180))-induced experimental autoimmune uveitis.
Haq E; Rohrer B; Nath N; Crosson CE; Singh I
J Ocul Pharmacol Ther; 2007 Jun; 23(3):221-31. PubMed ID: 17593005
[TBL] [Abstract][Full Text] [Related]
12. Suramin treatment suppresses induction of experimental autoimmune uveoretinitis (EAU) in rodents.
Sartani G; Silver PB; Strassmann G; Chan CC; Caspi RR
Curr Eye Res; 1995 Oct; 14(10):887-96. PubMed ID: 8549154
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.
Xu H; Strassmann G; Chan CC; Rizzo LV; Silver PB; Wiggert B; Caspi RR
Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):942-50. PubMed ID: 10102291
[TBL] [Abstract][Full Text] [Related]
14. Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye.
Wildner G; Thurau SR
Eur J Immunol; 1995 May; 25(5):1292-7. PubMed ID: 7774632
[TBL] [Abstract][Full Text] [Related]
15. Antigen-specific inhibition of experimental autoimmune uveoretinitis by bone marrow-derived immature dendritic cells.
Jiang HR; Muckersie E; Robertson M; Forrester JV
Invest Ophthalmol Vis Sci; 2003 Apr; 44(4):1598-607. PubMed ID: 12657598
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of experimental autoimmune uveoretinitis with anti-macrophage migration inhibitory factor antibodies.
Kitaichi N; Matsuda A; Kotake S; Namba K; Tagawa Y; Sasamoto Y; Ogasawara K; Iwabuchi K; Onoé K; Matsuda H; Nishihira J
Curr Eye Res; 2000 Feb; 20(2):109-14. PubMed ID: 10617911
[TBL] [Abstract][Full Text] [Related]
17. Effects of monoclonal antibodies directed at cell surface molecules on murine experimental autoimmune uveoretinitis.
Ando K; Fujino Y; Mochizuki M
Graefes Arch Clin Exp Ophthalmol; 1999 Oct; 237(10):848-54. PubMed ID: 10502060
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of aldose reductase attenuates endotoxin signals in human non-pigmented ciliary epithelial cells.
Yadav UC; Srivastava SK; Ramana KV
Exp Eye Res; 2010 May; 90(5):555-63. PubMed ID: 20138035
[TBL] [Abstract][Full Text] [Related]
19. Experimental autoimmune uveoretinitis (EAU) induced by retinal interphotoreceptor retinoid-binding protein (IRBP): differences between EAU induced by IRBP and by S-antigen.
Fox GM; Kuwabara T; Wiggert B; Redmond TM; Hess HH; Chader GJ; Gery I
Clin Immunol Immunopathol; 1987 May; 43(2):256-64. PubMed ID: 3494559
[TBL] [Abstract][Full Text] [Related]
20. Effect of type I interferon on experimental autoimmune uveoretinitis in rats.
Okada AA; Keino H; Fukai T; Sakai J; Usui M; Mizuguchi J
Ocul Immunol Inflamm; 1998 Dec; 6(4):215-26. PubMed ID: 9924918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
